Skip to main content
UniHealth

Doctor search

Margaret E Bates, MD

Obstetrics/Gynecology · Los Angeles

NPI 1407956527

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
Not verified
Not the same as out of network.
Offices
3
Since medical school
49 years
University of Southern California Keck School of Medicine, 1977

Offices

3 locations · Pih Health Physicians · 616 clinicians in this group

Looking this up.

Hospitals listed: USC Verdugo Hills Hospital. That is not proof they admit you there this week.

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bates’s office to ask if they take your plan before you enroll.

California Medical Board record

Licence G50676 · Current

Licensed to practise in California · since 1983 · expires 2028-08-31 · University of Southern California Keck School of Medicine.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

School, training and certification

What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.

Specialty certification

  • American Board of Obstetrics and Gynecology - Obstetrics and Gynecology

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • USC Verdugo Hills HospitalGlendale, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of University of Southern California, which runs 4 hospitalsPatients rate it 3 of 5 · 65% would definitely recommend it
    Overall rating: 4 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.19, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.5 to 1) · 396 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for USC Verdugo Hills Hospital

Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 1 better, 4 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at USC Verdugo Hills Hospital
Clostridium Difficile (C.Diff)Infections0.19BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.7 (0.5 to 1) · 396 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths0.92 (0 to 1.94) · 627 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths0.9 (0.51 to 1.28)No differentJul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths171.68 (110.02 to 233.35) · 27 casesNo differentJul 2022 – Jun 2024
Death rate for COPD patientsComplications and deaths8.4 · 73 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths12 · 48 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths7.4 · 246 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths11.3 · 343 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths10.8 · 70 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths3.7 · 1,469 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.18 (0 to 0.4) · 3,522 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.24 (0.03 to 0.44) · 3,622 casesNo differentJul 2022 – Jun 2024
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths3.54 (1.21 to 5.88) · 541 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths1.45 (0 to 3.06) · 163 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2.66 (1.03 to 4.29) · 511 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths11.7 (2.76 to 20.64) · 218 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths4.55 (0.5 to 8.6) · 189 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.69 (0.19 to 3.2) · 181 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.22 (0 to 1.01) · 2,841 casesNo differentJul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.263No differentOct 2024 – Sep 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections1.733No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits14.2 · 48 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits21.6 · 273 casesNoneJul 2023 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits2.6 · 298 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits28.2 · 377 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits17 · 392 casesNoneJul 2023 – Jun 2025
Rate of readmission after hip/knee replacementUnplanned return visits5.3 · 25 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20.9 · 90 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits11.2 (8.5 to 14.8) · 881 casesNo differentJan 2022 – Dec 2024

What patients said (413 patients answered, 23% of those asked)

Patient survey stars by topic at USC Verdugo Hills Hospital
Cleanliness4
Nurse communication3
Doctor communication2
Communication about medicines3
Discharge information3
Overall hospital rating3
Quietness1
Recommend hospital3
Share of patients giving the best answer at USC Verdugo Hills Hospital
Room was "always" clean77%
Nurses "always" communicated well76%
Doctors "always" communicated well75%
Staff "always" explained60%
Yes, staff "did" give patients this information84%
Yes, staff "did" give patients information about help after discharge82%
Doctors "always" explained things so they could understand73%
Doctors "always" listened carefully74%
Doctors "always" treated them with courtesy and respect80%
Patients who gave a rating of "9" or "10" (high)64%
Staff "always" explained new medications71%
Nurses "always" explained things so they could understand72%
Nurses "always" listened carefully74%
Nurses "always" treated them with courtesy and respect82%
"Always" quiet at night36%
"YES", patients would definitely recommend the hospital65%
Staff "always" explained possible side effects49%
Yes, staff "did" give patients information about possible symptoms85%

Original Medicare doctor bills

$4,660

Medicare paid this office $4,660 for 72 people.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Cervical or vaginal cancer screening; pelvic and clinical breast examination44$1,866$42
Short return visit17$974$42
Short return visit (20+ min)12$821$68

Who their Medicare patients are

72 Original Medicare patients in 2024. Average age 75 · Women 100% · Health risk score 0.76. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.

Conditions among them: High blood pressure 61% · Coronary heart disease 19% · Depression 19% · Diabetes 15% · Cancer 15%.

The office billed $13,524, Medicare allowed $5,728 and paid $4,660; for 95 services of 13 kinds.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
20247295750.76$13,524$4,660
202372129740.71$22,945$6,854
202279147730.77$21,800$9,529
202173136730.66$15,275$7,612
202074130740.69$15,275$7,149
2019109202740.75$22,035$9,949
2018101178730.94$18,840$8,490
2017138213740.84$28,395$9,690
2016153249740.82$37,220$11,838
2015152225730.89$36,865$12,111
2014145292730.84$41,753$14,864
201393134750.82$20,110$6,946

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 3 services

Original Medicare services billed in 2023
Cervical or vaginal cancer screening; pelvic and clinical breast examination51$2,186$43
Short return visit (20+ min)18$1,331$63
Short return visit16$1,090$47

2022: 4 services

Original Medicare services billed in 2022
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory47$2,299$49
Cervical or vaginal cancer screening; pelvic and clinical breast examination48$2,091$44
Return visit (30+ min)15$1,663$111
Short return visit (20+ min)17$1,273$71

2021: 4 services

Original Medicare services billed in 2021
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory52$2,571$49
Cervical or vaginal cancer screening; pelvic and clinical breast examination53$2,325$44
Return visit (30+ min)11$1,250$114
Short return visit (20+ min)13$974$70

2020: 3 services

Original Medicare services billed in 2020
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory46$2,252$49
Cervical or vaginal cancer screening; pelvic and clinical breast examination47$2,086$44
Short return visit (20+ min)18$1,073$54

2019: 4 services

Original Medicare services billed in 2019
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory62$3,022$49
Cervical or vaginal cancer screening; pelvic and clinical breast examination67$2,867$43
Short return visit (20+ min)37$2,316$54
Return visit (30+ min)13$990$71

2018: 3 services

Original Medicare services billed in 2018
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory67$3,151$47
Cervical or vaginal cancer screening; pelvic and clinical breast examination59$2,329$39
Short return visit (20+ min)34$1,791$47

2017: 4 services

Original Medicare services billed in 2017
Cervical or vaginal cancer screening; pelvic and clinical breast examination78$3,069$39
Short return visit (20+ min)56$3,046$45
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory27$1,261$47
Short return visit15$608$32

2016: 3 services

Original Medicare services billed in 2016
Short return visit (20+ min)78$4,739$48
Cervical or vaginal cancer screening; pelvic and clinical breast examination87$3,488$40
Short return visit26$1,040$32

2015: 4 services

Original Medicare services billed in 2015
Short return visit (20+ min)69$4,609$52
Cervical or vaginal cancer screening; pelvic and clinical breast examination79$3,221$41
Return visit (30+ min)19$1,326$66
Short return visit15$523$31

2014: 5 services

Original Medicare services billed in 2014
Cervical or vaginal cancer screening; pelvic and clinical breast examination99$4,045$41
Short return visit (20+ min)59$3,984$55
Return visit (30+ min)19$1,853$81
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory24$1,174$49
Short return visit15$432$27

2013: 4 services

Original Medicare services billed in 2013
Cervical or vaginal cancer screening; pelvic and clinical breast examination50$2,041$41
Short return visit (20+ min)22$1,361$62
Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory24$1,200$50
Short return visit12$489$38

Drugs they prescribed that Part D paid

$22,852

Pharmacies billed $22,852 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

Opioids were 0% of their Part D prescriptions (0 of 148) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.

119 generic and 29 brand-name prescriptions · $22,852 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Estradiol37$3,528$95
Estradiol (Twice Weekly)11$1,707$155

Year by year

Part D prescribing by year
2024148510% (0)20%$22,852
2023175490% (0)None$26,702
2022194430% (0)None$28,540
2021176410% (0)15%$21,938
2020181370% (0)31%$26,202
2019215450% (0)30%$28,560
2018250520% (0)34%$23,794
2017225450% (0)36%$22,392
2016238510% (0)39%$22,305
201525349None52%$24,663
2014257540% (0)60%$25,300
2013252450% (0)66%$23,279

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 3 drugs

Part D drugs prescribed in 2023
Estradiol (Twice Weekly)17$3,173$187
Estradiol31$2,886$93
Progesterone11$172$16

2022: 4 drugs

Part D drugs prescribed in 2022
Estradiol (Twice Weekly)20$2,994$150
Progesterone23$1,761$77
Estradiol17$920$54
Lorazepam12$65$5

2021: 5 drugs

Part D drugs prescribed in 2021
Estradiol (Twice Weekly)14$1,991$142
Progesterone21$1,880$90
Dotti12$829$69
Estradiol18$780$43
Lorazepam13$131$10

2020: 4 drugs

Part D drugs prescribed in 2020
Progesterone30$2,650$88
Estradiol (Twice Weekly)20$2,609$130
Estradiol16$555$35
Lorazepam14$47$3

2019: 4 drugs

Part D drugs prescribed in 2019
Premarin22$7,789$354
Estradiol62$6,887$111
Progesterone33$3,025$92
Lorazepam14$30$2

2018: 6 drugs

Part D drugs prescribed in 2018
Estradiol84$7,838$93
Premarin24$6,393$266
Progesterone32$2,532$79
Acyclovir11$561$51
Norethindrone Acetate12$246$21
Lorazepam13$35$3

2017: 4 drugs

Part D drugs prescribed in 2017
Premarin24$6,423$268
Estradiol49$4,291$88
Progesterone36$2,658$74
Norethindrone Acetate18$422$23

2016: 6 drugs

Part D drugs prescribed in 2016
Premarin27$5,882$218
Vagifem25$5,761$230
Estradiol48$3,576$74
Progesterone27$1,709$63
Norethindrone Acetate19$632$33
Medroxyprogesterone Acetate12$97$8

2015: 8 drugs

Part D drugs prescribed in 2015
Premarin40$8,677$217
Vagifem30$5,440$181
Estradiol35$2,838$81
Vivelle-Dot13$1,630$125
Acyclovir11$1,267$115
Progesterone29$983$34
Medroxyprogesterone Acetate11$80$7
Lorazepam15$37$2

2014: 7 drugs

Part D drugs prescribed in 2014
Premarin26$5,888$226
Vivelle-Dot43$4,946$115
Vagifem30$3,814$127
Prometrium12$1,595$133
Progesterone24$1,474$61
Estradiol17$534$31
Medroxyprogesterone Acetate15$197$13

2013: 6 drugs

Part D drugs prescribed in 2013
Premarin37$7,262$196
Vivelle-Dot46$4,495$98
Vagifem34$3,489$103
Progesterone31$2,432$78
Estradiol33$409$12
Medroxyprogesterone Acetate11$113$10

Money from drug and device companies

$68 in 2025

Industry payments by year
202523None$68
202422None$185
202047None$127
2019929None$525

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Hologic Sales and ServiceThinprep 2000 Processor$46
2 payments
  • Meals for Thinprep 2000 Processor · 2025-10-02 · $25
  • Meals for Aptima · 2025-09-15 · $21
Merck Sharp & DohmeGardasil 9$22
1 payment
  • Meals for Gardasil 9 · 2025-11-18 · $22
See all 3 published payments
Every published payment
Merck Sharp & DohmeMeals · 2025-11-18Gardasil 9$22
Hologic Sales and ServiceMeals · 2025-10-02Thinprep 2000 Processor$25
Hologic Sales and ServiceMeals · 2025-09-15Aptima$21
See earlier years (2024, 2020, 2019)

2024: $185

Payments by company in 2024
ShockWave MedicalShockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter$165
1 payment
  • Meals for Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter · 2024-01-17 · $165
Astellas Pharma USVeozah$21
1 payment
  • Meals for Veozah · 2024-03-29 · $21

2020: $127

Payments by company in 2020
AbbVieOrilissa$57
3 payments
  • Meals for Lo Loestrin Fe · 2020-09-10 · $19
  • Meals for Orilissa · 2020-03-03 · $24
  • Meals for Orilissa · 2020-02-11 · $14
Avion PharmaceuticalsBalcoltra$32
2 payments
  • Meals for Balcoltra · 2020-07-31 · $13
  • Meals for Balcoltra · 2020-01-23 · $19
AllerganLo Loestrin Fe$22
1 payment
  • Meals for Lo Loestrin Fe · 2020-07-02 · $22
TherapeuticsMDImvexxy$16
1 payment
  • Meals for Imvexxy · 2020-11-17 · $16

2019: $525

Payments by company in 2019
AbbVieOrilissa$143
9 payments
  • Meals for Orilissa · 2019-11-21 · $21
  • Meals for Orilissa · 2019-10-09 · $19
  • Meals for Orilissa · 2019-08-08 · $24
  • Meals for Orilissa · 2019-05-06 · $11
  • Meals for Orilissa · 2019-05-06 · $2
  • Meals for Orilissa · 2019-04-24 · $3
  • Meals for Orilissa · 2019-04-24 · $19
  • Meals for Orilissa · 2019-04-04 · $19
  • Meals for Orilissa · 2019-01-31 · $24
TherapeuticsMDImvexxy$116
7 payments
  • Meals for Bijuva · 2019-12-04 · $24
  • Meals for Bijuva · 2019-11-12 · $5
  • Meals for Imvexxy · 2019-10-01 · $23
  • Meals for Imvexxy · 2019-09-19 · $8
  • Meals for Imvexxy · 2019-07-23 · $18
  • Meals for Imvexxy · 2019-04-23 · $16
  • Meals for Imvexxy · 2019-02-12 · $21
Avion PharmaceuticalsPrenate Mini$95
5 payments
  • Meals for Prenate Mini · 2019-10-08 · $20
  • Meals for Prenate Mini · 2019-06-22 · $19
  • Meals for Prenate Mini · 2019-06-05 · $18
  • Meals for Prenate Mini · 2019-05-01 · $19
  • Meals for Balcoltra · 2019-02-05 · $19
HologicAptima Combo 2$51
2 payments
  • Meals for Novasure · 2019-03-25 · $23
  • Meals for Aptima Combo 2 · 2019-01-17 · $28
ColoplastAltis$38
1 payment
  • Education for Altis · 2019-05-07 · $38
Bayer HealthCare PharmaceuticalsKyleena$27
2 payments
  • Meals for Kyleena · 2019-06-17 · $11
  • Meals for Kyleena · 2019-05-09 · $16
Sanofi PasteurFluzone High-Dose$21
1 payment
  • Meals for Fluzone High-Dose · 2019-10-30 · $21
Vertical PharmaceuticalsRelexxii$18
1 payment
  • Meals for Relexxii · 2019-11-27 · $18
Merck Sharp & DohmeNuvaring$17
1 payment
  • Meals for Nuvaring · 2019-04-25 · $17

Checkups this office reported

Medicare did not publish checkup rates for this clinician.

Medicare’s overall office score
76.3 / 100
Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.

Professional record

NPI
1407956527
Licence
CA G50676California G50676: Current · expires 2028-08-31
Trained
University of Southern California Keck School of Medicine, 1977 · 49 years ago
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
Yes
Taxonomy
Federal specialty code 207V00000X (207V00000X)
Mailing address
637 Lucas Ave, Suite 200, Los Angeles, CA, 90017
NPI first listed
2006-09-25
NPI last updated
2007-07-08

This is when the NPI record was last certified, not a medical board exam.